希慎興業(00014.HK)跌逾3% 去年虧損收窄但減派息
希慎興業(00014.HK)今早高開0.43%,早段高見14.06元,升1.88%後回軟。公布業績後跌幅擴大,現報13.34元,跌3.33%,成交104.9萬股,涉資1,424.56萬元。
公司截至去年12月底止全年營業額32.1億元,按年跌7.2%。虧損收窄至8.72億元,上年同期蝕11.57億元;每股虧損85仙。派第二次中期息81仙,上年同期派117仙。全年總派息108仙,對上財年總派息144仙。
期內基本溢利18.32億元,按年下跌14%。投資物業組合於去年底估值為960.05億元,按年下跌0.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.